Wilson Sonsini Goodrich & Rosati is advising DTx Pharma on the transaction. A preclinical-stage biotechnology company, DTx Pharma announced that it has been acquired by Novartis. In addition...
Novartis’ Acquisition of DTx Pharma
Aadi Bioscience’s $72.5 Million Private Placement Equity Financing
Wilson Sonsini represented Aadi Bioscience, Inc. on the deal. Aadi Bioscience, Inc., a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in...